Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Nature Communications
|
April 28, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
Mara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2019
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†
H Ghesquieres, M Chevrier, M Laadhari, et al.
Medical Mycology
|
June 1, 2026
Metformin exerts a dual effect on Mucorales virulence by altering oxidative metabolism through the regulation of rhizoferrin levels
J Alberto Patiño-Medina, Viridiana Alejandre-Castañeda, César J Torres-Cortés, et al.
Bone Marrow Transplantation
|
November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT
L Sellner, A Boumendil, H Finel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2021
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]
G Fossard, F Broussais, I Coelho, et al.
Bone Marrow Transplantation
|
May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
L Bento, A Boumendil, H Finel, et al.
ESMO Open
|
January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
P Heudel, S Chabaud, D Perol, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Nature Communications
|
April 28, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
Mara Pavel-Dinu, Volker Wiebking, Beruh T Dejene, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2019
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†
H Ghesquieres, M Chevrier, M Laadhari, et al.
Medical Mycology
|
June 1, 2026
Metformin exerts a dual effect on Mucorales virulence by altering oxidative metabolism through the regulation of rhizoferrin levels
J Alberto Patiño-Medina, Viridiana Alejandre-Castañeda, César J Torres-Cortés, et al.
Bone Marrow Transplantation
|
November 17, 2015
Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT
L Sellner, A Boumendil, H Finel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2017
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G Fossard, F Broussais, I Coelho, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2019
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
C Soussain, S Choquet, M Blonski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2021
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723]
G Fossard, F Broussais, I Coelho, et al.
Bone Marrow Transplantation
|
May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
L Bento, A Boumendil, H Finel, et al.
ESMO Open
|
January 30, 2021
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
P Heudel, S Chabaud, D Perol, et al.
Page
of 10